Status:
RECRUITING
Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
Lead Sponsor:
Emine Kanmaz
Collaborating Sponsors:
Kocaeli University
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
12-17 years
Phase:
PHASE4
Brief Summary
This study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group...
Detailed Description
Social anxiety disorder (SAD) is a common psychiatric condition that often begins in adolescence and causes significant impairment in academic, social, and occupational functioning. Although selective...
Eligibility Criteria
Inclusion
- RESEARCH ARM:
- Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic
- Have normal intelligence based on clinical observation
- Be between 12 and 17 years of age
- Have a diagnosis of SAD
- Have refused medication recommended for SAD
- For SAD; are not currently receiving medical treatment
- Have received written consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them
- Have volunteered to participate in the study through an invitation poster presentation
- CONTROL ARM:
- 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. Have refused medication recommended for SAD 6. For SAD; are not currently receiving medical treatment 7. Have obtained written informed consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them 8. Have volunteered to participate in the study through an invitation poster presentation
- CONTROL ARM:
- 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. For SAD; Not currently receiving medical treatment 6. Volunteer 7. Written consent for participation in the study must be obtained from the patient and/or their first-degree relative authorized to make decisions about them.
- 8\. Accept sertraline treatment, routinely used in outpatient clinic follow-ups for SAD, and volunteer for the study.
Exclusion
- RESEARCH ARM:
- Substance use disorder
- Schizophrenia and bipolar disorder
- Autism spectrum disorder
- Cognitive disability
- Neurological disorder
- Balance disorder
- Patients who have received SSRI treatment for SAD in the last 6 months
- CONTROL ARM:
- Substance use disorder
- Schizophrenia and bipolar disorder
- Autism spectrum disorder
- Cognitive disability
- Patients who have received SSRI treatment for SAD within the last 6 months -
Key Trial Info
Start Date :
November 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT07192367
Start Date
November 15 2024
End Date
December 1 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University Hospital - Department of Child and Adolescent Psychiatry
Kocaeli, Turkey (Türkiye), 41000